I love little-elves companies, and no, I�� not referring to anything like the technical analysts dubbed ��lves��by the late Louis Rukeyser on his classic PBS weekly show, Wall Street Week.
I�� referring instead to situations where you read or hear about a company�� business and blurt out something like: �� didn�� know that sort of thing was done by publicly-traded corporations. I thought it was done by little elves.��nbsp; Forbes Low Priced Stock Report�� Top 40-company Insignia Systems Insignia Systems, which makes retail store shelf labels and small product signs (communicating information about prices, often in the context of promotion) is just such a company.
Those of us who still go to brick-and-mortar stores, which is pretty much all of us on many if not all days, encounter such labels (whether made by ISIG or others) all the time. Admittedly, we don�� always pay close attention to them and often reflexively reach for what we usually buy.
Top 5 Low Price Companies To Invest In Right Now: Hospira Inc (HSP)
Hospira, Inc. (Hospira), incorporated on September 16, 2003, is a provider of injectable drugs and infusion technologies. Hospira's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira's portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. Hospira conducts operations worldwide and is managed in three reportable segments: Americas; Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment includes the United States, Canada and Latin America; the EMEA segment includes Europe, the Middle East and Africa, and the APAC segment includes Asia, Japan, Australia and New Zealand. In all segments, Hospira sells a line of products, including specialty injectable and other pharmaceuticals and medication management products.
Specialty Injectable Pharmaceuticals
Hospira's specialty injectable pharmaceutical products consist of generic injectable pharmaceuticals. The other drugs' therapeutic areas include analgesia, anesthesia, anti-infectives, cardiovascular, oncology, and other areas. All of Hospira's generic injectable pharmaceuticals in the United States include unit-of-use bar-code labels that can be used to support medication delivery. Hospira primarily procures the active pharmaceutical ingredients in these products from third-party suppliers. During the year ended December 31, 2011, Hospira portfolio included 87 injectable drug launches consisting of 13 compounds. Among these launches included, in the United States, docetaxel (an oncolytic drug used to treat a variety of cancers), topotecan (an oncolytic drug used for the treatment of small cell lung cancer) and imipenem-cilastatin (a beta-lactam antibiotic). Hospira also launched a solution formulation of gemcitabine (an oncolytic drug used to treat a variety of cancers), which augmented Hospira's portfolio of gemcitabin! e products. New-to-country launches in EMEA in 2011, included topotecan, meropenem, gemcitabine, imipenem-cilastatin, remifentanil, docetaxel and levofloxacin. New-to-country launches in APAC in 2011, included docetaxel, piperacillin tazobactam, oxaliplatin, meropenem and gemcitabine. Hospira's specialty injectable pharmaceutical products also include Precedex (dexmedetomidine HCl), a sedative. Precedex is licensed to Hospira by Orion Corporation in the Americas and APAC segments, and in the Middle East and Africa.
Hospira sells and markets Precedex for use in non-intubated patients requiring sedation, as well as intubated and mechanically ventilated patients. Hospira's specialty injectable pharmaceuticals also include biologic products, which are molecules derived from cells that are demonstrated to be similar to an approved originator product. Hospira's biosimilar, Retacrit, was available in 20 EMEA countries during 2011. Its second biosimilar, Nivestim, was launched during the year ended December 31, 2010, and was available in 21 countries, including Australia, where the biosimilar filgrastim product was launched in 2011. Hospira's drug delivery formats include offerings in ampules and flip-top vials, which clinicians can use with standard syringes. Hospira's drug delivery options include Carpuject and iSecure prefilled syringes, AnsyrTM prefilled needleless emergency syringe systems, First Choice ready-to-use premix and the ADD-Vantage system for preparing drug solutions from prepackaged drug powders or concentrates.
Other Pharmaceuticals
Hospira's other pharmaceuticals primarily consist of intravenous (I.V.) solutions, nutritionals and contract manufacturing services. Hospira offers infusion therapy solutions and related supplies that include I.V. solutions for general use, I.V. nutrition products, and solutions for the washing and cleansing of wounds or surgical sites. All of Hospira's injectable I.V. solutions in the United States include unit-of-use bar-c! ode label! s that can be used to support medication management efforts. Hospira also offers infusion therapy solutions in its VisIV non-PVC, non-DEHP I.V. container, an I.V. bag. Hospira's contract manufacturing services are offered through its One2One services group, which provides formulation development, filling and finishing of injectable and oral drugs worldwide. Hospira works with its pharmaceutical and biotechnology customers to develop injectable forms of their drugs, and Hospira fills and finishes those and other drugs into containers and packaging selected by the customer. The customer then sells the finished products under its own label. Hospira's One2One manufacturing services group generally does not manufacture active pharmaceutical ingredients, but offers a range of filling and finishing services in a variety of delivery systems.
Medication Management
Medication management products include electronic drug delivery pumps, safety software and disposable administration sets dedicated to Hospira pumps. These sets are used to deliver I.V. fluids and medications. Hospira also offers software maintenance agreements and other service offerings. Hospira's electronic drug delivery pumps include Hospira's general infusion system, Symbiq; the Plum A+ line of infusion pumps; Hospira's patient-controlled analgesia device, LifeCare PCA; the GemStar ambulatory infusion pump; and the Plum XLD infusion pump. Hospira offers the Hospira MedNet safety software system, which has been designed to enable hospitals to customize intravenous drug dosage limits and track drug delivery to prevent medication errors. The wireless network version of the Hospira MedNet system establishes real-time send-and-receive capability and can interface with select hospital and pharmacy information systems. The Hospira MedNet system is standard in the Symbiq infusion system, and is also available as an additional feature for the Plum A+ line, and LifeCare PCA devices. Hospira also offers safety software with its Ge! mStar pum! p.
Medication management includes TheraDoc, Inc. products, which are module-based clinical surveillance systems that provide patient safety surveillance and clinical decision support. Medication management also includes gravity administration sets and other device products, including needlestick safety products and programs to support Hospira's customers' needlestick prevention initiatives. LifeShield CLAVE and LifeShield MicroCLAVE connectors are one-piece valves that directly connect syringes filled with medications to a patient's I.V. line without the use of needles. ICU Medical's CLAVE connectors are a component of administration sets sold by Hospira to its customers in the United States and select markets outside the United States.
The Company competes with Baxter International Inc., Boehringer Ingelheim, Fresenius Kabi, Pfizer, Sandoz, Sanofi, Teva Pharmaceuticals, B. Braun Melsungen AG, CareFusion, Terumo, Actavis, Intas Pharmaceuticals, Ltd, Medac GmbH, Mylan Inc., Sun Pharmaceutical Industries, Ltd. and Aspen.
Advisors' Opinion:- [By Ben Levisohn]
Shares of Allergan have gained 2.5% to $114.78 today at 3:44 p.m., while�Merck�(MRK) has risen 2.4% to $53.33, Hospira�(HSP) has ticked up 0.1% to $42.51�and Eli Lily�(LLY) has advanced 0.7% to $53.04.
- [By Saumya Vaishampayan]
Hospira Inc. (HSP) �shares gained 7%. The company on Wednesday posted a 58% surge in third-quarter profit as revenue edged up 1.4%, with adjusted profit and sales beating expectations.
- [By Holly LaFon]
A few weaker sectors lagged the broad market advance. The energy, telecommunication services, and utilities groups gained ground but at a slower pace than most other S&P 500 sectors. Hess was a welcome exception in energy. Most of our investments in the lagging sectors moved higher but trailed the broad market. Our most disappointing energy holdings shared a common theme: exposure to the mining industry. As concerns about the pace of global economic growth intensified, particularly in emerging markets like China, our positions in Cliffs Natural Resources, Newmont Mining, and Joy Global were negatively affected. Fortunately, these composed relatively small positions in the portfolio. The Major Portfolio Changes table on page 8 shows the stocks in which we were active buyers and sellers during the first half of the year. We initiated positions in Apple (AAPL), Joy Global (JOY), Hospira (HSP), and Western Union (WU), all of which had stumbled in the eyes of investors, resulting in sharply falling share prices before we decided to invest in them. Consequently, the companies' stock valuations became more attractive to us. We normally favor companies whose share prices have declined because of cyclical worries, sector concerns, or company-specific issues. When a stock falls in value, its price/earnings ratio usually declines while its dividend yield increases, characteristics we look for as value investors. The strategy can be rewarding as long as the company's fundamentals are still sound.
- [By Lauren Pollock]
Among the companies with shares expected to actively trade in Wednesday’s session are Tesla Motors Inc.(TSLA) Humana Inc.(HUM) and Hospira Inc.(HSP)
Top 5 Low Price Companies To Invest In Right Now: AEP Industries Inc.(AEPI)
AEP Industries Inc. engages in the production, manufacture, and distribution of plastic packaging products in the United States and Canada. The company offers a line of polyethylene, polyvinyl chloride, and polypropylene flexible packaging products for consumer, industrial, and agricultural applications. Its products include custom films for industrial applications, including sheeting, tubing, and bags; films that protect items stored outdoors or in transit, such as boats and cars; a range of shrink films, barrier films, and overwrap films; stretch film products for hand wrap and rotary applications; and pre stretch and high performance products for commodity and specialty uses. The company also provides food wraps products, including blown plastic film fold-top bags, twist-tie bags, and food containers under the Seal Wrap brand for the supermarket and industrial markets; a range of coextruded polyolefin films and monolayer films for food, pharmaceutical, and medical appli cations; and canliners product line comprising trash bags and institutional bags. In addition, it offers printed rollstock to the food and beverage industries, and manufacturing and distributing companies; and unplasticized polyvinyl chloride films for use in battery labels, twist films, and credit card laminates; and various film products with agricultural applications, such as silage, smooth mulch films, and fumigation films. Further, the company provides disposable consumer and institutional plastic products, which include table covers and skirts, aisle runners, aprons, bibs, gloves, boots, freezer/storage bags, saddle pack bags, locker wrap and custom imprint designs for the food service, party supply, and school/collegiate markets under the Sta-Dri brand. AEP Industries Inc. markets its products directly to end-users, as well as through distributors. The company was founded in 1970 and is based in South Hackensack, New Jersey.
Advisors' Opinion:- [By Brian Pacampara]
What: Shares of plastic packaging manufacturer AEP Industries (NASDAQ: AEPI ) sank 14% today after its quarterly results and outlook disappointed Wall Street.
- [By Victor Selva]
Competitors such as AEP Industries Inc. (AEPI) and Lockheed Martin Corporation (LMT) will be better options in term of ROE.
Final Comment
Top 10 Dividend Stocks For 2014: WiLan Inc (WILN)
WiLAN Inc. (WiLAN), incorporated on May 14, 1992, is a licensing company. WiLAN develops, acquires, and licenses a range of intellectual property that drives products in communications and consumer electronics markets. Through both internal research and development and acquisitions from third parties, the Company has acquired intellectual property in the form of patents and patent applications in many countries that it has licensed to more than 255 companies in telecommunications markets around the world. As of December 31, 2011, WiLAN had a portfolio of approximately 3,000 patents, including issued and pending patents and foreign equivalents. WiLAN has five directly wholly-owned subsidiaries, Wi-LAN Capital Inc. (WiLAN Capital), Wi-LAN International Inc. (WiLAN International), Wi-LAN International Hong Kong Inc. (WiLAN Hong Kong), Wi-LAN International Japan Inc. (WiLAN Japan) and Wi-LAN International Taiwan Inc. In July 2012, it acquired a global portfolio of more than 40 patents and applications from Siemens AG related to telecommunication network management and mobile multimedia. In October 2012, the Company acquired a global portfolio of more than 150 patents and patent applications from Alvarion Ltd. In June 2013, WiLan Inc acquired a portfolio of patents from Cypress Semiconductor Corporation. In November 2013, the Company acquired a portfolio of semiconductor patents from IXYS CH GmbH related to microcontroller technology.
In the Company's licensing business, the Company has signed licenses with companies that sell products utilizing technologies, including CDMA (Code Division Multiple Access-a cellular telecommunications specification); Wi-Fi (the underlying technology of wireless local area networks based on various IEEE 802.11 specifications); WiMAX (Worldwide Interoperability for Microwave Access-a standards-based broadband wireless technology that provides metropolitan area network connectivity based on IEEE 802.16 specifications); LTE (Long Term Evolution-high performance air! interface for cellular mobile communication systems designed to increase the capacity and speed of mobile telephone networks), and ADSL (Asymmetric Digital Subscriber Line-a standards-based access technology that provides broadband Internet access over twisted pair telecommunications wiring). The Company has also signed licenses with companies that sell products utilizing technologies, including DOCSIS (Data Over Cable Service Interface Specifications-a standards-based access technology that provides broadband Internet access over cable networks); Bluetooth (a wireless protocol for exchanging data over short distances between fixed and mobile devices), and V-Chip (a technology that permits the blocking of television programs at a receiver (such as a television, multi-media equipped personal computer or set-top box) by viewers based on ratings information carried on the television signal).
Advisors' Opinion:- [By Monica Gerson]
Breaking news
Wi-LAN (NASDAQ: WILN) today announced that its Board of Directors has initiated a process to explore and evaluate a broad range of strategic alternatives for the Company to enhance shareholder value. To read the full news, click here. MannKind (NASDAQ: MNKD) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of a New Drug Application (NDA) for AFREZZA庐 (insulin human [rDNA origin]) Inhalation Powder. To read the full news, click here. lululemon athletica (NASDAQ: LULU) today announced that Tara Poseley has been appointed to its Senior Leadership Team as Chief Product Officer. To read the full news, click here. Nice Systems (NASDAQ: NICE) reported a drop in its third-quarter profit. To read the full news, click here.Posted-In: Bank of America FOMC US Stock FuturesNews Eurozone Futures Pre-Market Outlook Markets
- [By Rich Duprey]
Often accused of being a patent troll,�non-performing entity�WiLAN� (NASDAQ: WILN ) wrangled a settlement out of Dell (NASDAQ: DELL ) with details of the deal remaining confidential.
Top 5 Low Price Companies To Invest In Right Now: Astrotech Corporation(ASTC)
Astrotech Corporation operates as a commercial aerospace company in the United States. The company provides spacecraft payload processing and related services; designs and manufactures space hardware; and commercializes space technologies for use on the earth. It also offers satellite launch processing support to government and commercial customers for their communication, earth observation, and deep space satellites. The company?s processing activities consist of satellite ground transportation; pre-launch hardware integration and testing; satellite encapsulation, fueling, launch pad delivery; and communication linked launch control, as well as engineering services. In addition, it develops Miniature Chemical Detector, a chemical analyzer for use on international space station, as well as detects residues and vapors from a range of chemicals, including explosives, chemical warfare agents, toxic chemicals, and volatile organic compounds. The company serves the United Stat es Government and commercial satellite and spacecraft customers. Astrotech Corporation was founded in 1984 is headquartered in Austin, Texas.
Advisors' Opinion:- [By Roberto Pedone]
Astrotech (ASTC) operates as a commercial aerospace company in the U.S. This stock closed up 7.2% to $3.26 a share in Thursday's trading session.
Thursday's Range: $3.02-$3.31
52-Week Range: $0.61-$4.05
Thursday's Volume: 295,000
Three-Month Average Volume: 570,805From a technical perspective, ASTC spiked sharply higher here right above some near-term support at $2.96 with lighter-than-average volume. This stock has been uptrending strong for the last four months, with shares moving higher from its low of 63 cents per share to its recent high of $4.05. During that uptrend, shares of ASTC have been making mostly higher lows and higher highs, which is bullish technical price action. This spike on Thursday is now starting to push shares of ASTC within range of triggering a major breakout trade. That trade will hit if ASTC manages to take out some near-term overhead resistance levels at $3.50 to $3.75 and then once it takes out its 52-week high at $4.05 with high volume.
Traders should now look for long-biased trades in ASTC as long as it's trending above its 50-day at $2.66 or above more near-term support at $2.62 and then once it sustain a move or close above those breakout levels with volume that hits near or above 570,805 shares. If that breakout hits soon, then ASTC will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside targets of that breakout are $5 to $5.50.
Top 5 Low Price Companies To Invest In Right Now: Fomento de Construcciones y Contratas SA (FCC)
Fomento de Construcciones y Contratas SA (FCC) is a Spain-based company, which is primarily engaged, together with its subsidiaries in the construction and environmental services sector. The Company�� activities include the collection, treatment and elimination of solid urban waste, street cleaning, sewer system maintenance, green areas and buildings maintenance, urban transport, treatment and elimination of industrial waste, full-service water supply management and cement manufacture. The Company is also active in the real estate development, as well as in the renewable energy industry. In addition, the Company is a parent of Grupo FCC, a group which comprises a number of controlled entities. Advisors' Opinion:- [By Live Investor]
What does the FCC have to say? The regulator�� reaction is nothing surprising. After Son met the Federal Communications Commission (FCC) to convince them about the prospects of the proposed deal, Reuters reported that FCC chairman Tom Wheeler wasn�� quite impressed and had dubious thoughts on it.
No comments:
Post a Comment